已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

A prospective multicentre controlled study of Gaoweikang (Chinese multiherb extract-based tincture) used in high-risk HPV infections.

医学 内科学 B组 前瞻性队列研究 酊剂(纹章学) 胃肠病学 外科 传统医学
作者
Chen Lm,Cong Qi,Deqing Wu,Pei‐Jer Chen,Lugui Qiu,Zhi-Jie Hong,Ying Yang,Xu Liu,Wang Lf,Li Huang,W-R Li,Jiyu Tang,Yongli Cao,Lu-Lu Sui
出处
期刊:PubMed [National Institutes of Health]
卷期号:27 (19): 8985-8992
标识
DOI:10.26355/eurrev_202310_33922
摘要

The aim of the study was to investigate the safety and antiviral efficacy of a Chinese multiherb extract-based tincture (GWK) on a population of patients with high-risk human papilloma (hrHPV) infections and hrHPV-caused cervical low-grade squamous intraepithelial lesions (LSILs).Patients with persistent hrHPV infection were enrolled in Group A, including A1 subjects, who received the intervention, and A2 subjects, who received the control. Patients with hrHPV infection causing cervical LSIL were enrolled in Group B, which included B1 subjects, who received the intervention, and B2 subjects, who served as the control. For Groups A1 and B1, hrHPV was tested at 3 months (M3) and 6 months (M6) after the intervention. The side effects were also analyzed.At baseline (D0), a total of 99 patients were enrolled in Group A, with 50 subjects in Group A1 and 49 subjects in Group A2. A total of 91 patients were enrolled in Group B, with 45 subjects in Group B1 and 46 subjects in Group B2. There was no significant difference in the characteristics, including average age, age stratification, and HPV genotype. At M6, both Group A1 and Group B1 had a higher hrHPV clearance rate than the control group (A1/A2: 80.0% vs. 20.4%; B1/B2: 64.4% vs. 15.2%, p<0.001). At M6, the effective rates of Group A1 and Group B1 were 84% (42/50) and 68.9% (31/45), respectively. The side effect rates of Groups A1 and B1 were 11.5% (6/52) and 11.1% (5/45), respectively. Most adverse reactions involved local discomfort, including vulvar erythema, vulvar itch, increased vaginal discharge, cervical bleeding, and mild pain in the lower abdomen. Univariate logistic regression analysis showed that the intervention had an OR of 12 (95% CI 4.431-32.50) for clearing persistent HPV infection (p<0.001). For cervical LSIL, the intervention had an OR of 10.1 for clearing persistent HPV infection (95% CI 3.68-27.7) (p<0.001).The results of this study suggest that the Chinese multiherb extract-based tincture GWK is safe and well tolerated. Furthermore, this preliminary study showed that this Chinese multiherb extract-based tincture is helpful for promoting HPV clearance in cases of persistent HPV and HPV-induced LSIL.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
1秒前
池鱼完成签到,获得积分10
3秒前
zizi完成签到,获得积分10
3秒前
3秒前
4秒前
莫之玉完成签到 ,获得积分10
4秒前
饭团完成签到,获得积分20
5秒前
无题完成签到,获得积分10
5秒前
AA发布了新的文献求助10
6秒前
7秒前
等风的拾荒者完成签到 ,获得积分10
7秒前
9秒前
Zhao完成签到,获得积分10
10秒前
yolo发布了新的文献求助10
11秒前
完美元柏发布了新的文献求助10
14秒前
gq100520发布了新的文献求助10
15秒前
清爽慕山完成签到 ,获得积分10
16秒前
齐欢完成签到,获得积分10
18秒前
所所应助霖lin采纳,获得10
18秒前
18秒前
爱笑灵雁完成签到,获得积分10
20秒前
饭团发布了新的文献求助20
21秒前
xuan完成签到 ,获得积分10
22秒前
22秒前
mmyhn应助科研通管家采纳,获得20
22秒前
领导范儿应助科研通管家采纳,获得10
22秒前
无极微光应助科研通管家采纳,获得20
22秒前
英姑应助科研通管家采纳,获得10
23秒前
脑洞疼应助科研通管家采纳,获得10
23秒前
赘婿应助科研通管家采纳,获得10
23秒前
mmyhn应助科研通管家采纳,获得20
23秒前
23秒前
华仔应助科研通管家采纳,获得10
23秒前
mmyhn应助科研通管家采纳,获得20
23秒前
shark完成签到,获得积分10
23秒前
23秒前
geen完成签到,获得积分10
24秒前
24秒前
爱笑灵雁发布了新的文献求助10
24秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Essentials of Carbohydrate Chemistry and Biochemistry, 4th Edition 600
Organizational Behavior 510
Management and the Arts 510
Matrix Methods in Data Mining and Pattern Recognition Second Edition 510
Rosenblum, Global Change Biology 500
CLSI VET01S-2024 Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated From Animals (7th Ed) 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 化学工程 工程类 有机化学 物理 复合材料 生物化学 内科学 细胞生物学 基因 遗传学 免疫学 冶金 光电子学 癌症研究
热门帖子
关注 科研通微信公众号,转发送积分 7772067
求助须知:如何正确求助?哪些是违规求助? 9314525
关于积分的说明 20339111
捐赠科研通 7357435
什么是DOI,文献DOI怎么找? 3316879
关于科研通互助平台的介绍 2465370
邀请新用户注册赠送积分活动 2331888